Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > No follow through

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Jan 12, 2021 12:38pm

191 Views

Post# 32276610

RE:RE:RE:RE:No follow through

Agree regardless of the range SGTX has been in since the IPO it's clear SVA is massively undervalued by an order of magnitude from its peers. We are only days away from Witkowski releasing data. I'm not expecting a miracle as Philip has mentioned we won't have a binary outcome at this stage but welcome the data that will put us even further ahead of our peers and validate the next steps moving forward. Plenty of wild cards that could come into play but with close to a full cohort showing positive results and the data to support that institutional and big pharma money can change this game very quickly.

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?